Literature DB >> 20049843

Preference-based condition-specific measures of health: what happens to cross programme comparability?

John Brazier, Aki Tsuchiya.   

Abstract

Mesh：

Year:  2010        PMID： 20049843     DOI： 10.1002/hec.1580

Source DB:  PubMed          Journal:  Health Econ        ISSN： 1057-9230            Impact factor:   3.046


× No keyword cloud information.
  28 in total

Review 1.  Evaluation of content on EQ-5D as compared to disease-specific utility measures.

Authors:  Fang-Ju Lin; Louise Longworth; A Simon Pickard
Journal:  Qual Life Res       Date:  2012-06-23       Impact factor: 4.147

Review 2.  Using QALYs in cancer: a review of the methodological limitations.

Authors:  Martina Garau; Koonal K Shah; Anne R Mason; Qing Wang; Adrian Towse; Michael F Drummond
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

3.  Korean guidelines for pharmacoeconomic evaluation (second and updated version) : consensus and compromise.

Authors:  Seungjin Bae; Soook Lee; Eun Young Bae; Sunmee Jang
Journal:  Pharmacoeconomics       Date:  2013-04       Impact factor: 4.981

4.  Utility estimation in chronic obstructive pulmonary disease: a preference for change?

Authors:  Jennifer Petrillo; Floortje van Nooten; Paul Jones; Maureen Rutten-van Mölken
Journal:  Pharmacoeconomics       Date:  2011-11       Impact factor: 4.981

Review 5.  The Role of Condition-Specific Preference-Based Measures in Health Technology Assessment.

Authors:  Donna Rowen; John Brazier; Roberta Ara; Ismail Azzabi Zouraq
Journal:  Pharmacoeconomics       Date:  2017-12       Impact factor: 4.981

Review 6.  Assessment of the construct validity and responsiveness of preference-based quality of life measures in people with Parkinson's: a systematic review.

Authors:  Yiqiao Xin; Emma McIntosh
Journal:  Qual Life Res       Date:  2016-10-24       Impact factor: 4.147

Review 7.  Health state values for use in the economic evaluation of treatments for Alzheimer's disease.

Authors:  James Shearer; Colin Green; Craig W Ritchie; John P Zajicek
Journal:  Drugs Aging       Date:  2012-01-01       Impact factor: 3.923

8.  Empirical Validity of a Generic, Preference-Based Capability Wellbeing Instrument (ICECAP-A) in the Context of Spinal Cord Injury.

Authors:  Cassandra Mah; Vanessa K Noonan; Stirling Bryan; David G T Whitehurst
Journal:  Patient       Date:  2021-03       Impact factor: 3.883

Review 9.  The prediction and monitoring of toxicity associated with long-term systemic glucocorticoid therapy.

Authors:  Emma Harris; Ana Tiganescu; Sandy Tubeuf; Sarah Louise Mackie
Journal:  Curr Rheumatol Rep       Date:  2015-06       Impact factor: 4.592

Review 10.  Conceptualising 'Benefits Beyond Health' in the Context of the Quality-Adjusted Life-Year: A Critical Interpretive Synthesis.

Authors:  Lidia Engel; Stirling Bryan; David G T Whitehurst
Journal:  Pharmacoeconomics       Date:  2021-08-23       Impact factor: 4.981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.